SCHEMBL10142469

SCHEMBL10142469

Cc1cc2ccc3cnccc3c2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 1/20 0.45
▸ CCND1 P24385 1/20 0.45
▸ DYRK1A Q13627 5/20 0.43
▸ CDK5 Q00535 3/20 0.43
▸ KDR P35968 2/20 0.43
▸ AURKA O14965 1/20 0.43
▸ DAPK3 O43293 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ ROCK2 O75116 1/20 0.43
▸ CHEK2 O96017 1/20 0.43
▸ CDK1 P06493 1/20 0.43
▸ PIM1 P11309 1/20 0.43
▸ FGFR1 P11362 1/20 0.43
▸ PRKACA P17612 1/20 0.43
▸ RPS6KB1 P23443 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ MARK3 P27448 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ AKT1 P31749 1/20 0.43
▸ FLT4 P35916 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16892342 0.76 KDM4E (0.48) DYRK1AKDM4EALDH1A1HPGDHTT
SCHEMBL3606588 0.76 CLK1 (0.44) CDK4CCND1DYRK1ACDK5KDR
SCHEMBL16650949 0.75 KDM4E (0.58) CSNK2A1KDM4EPDE3BPDE3A
SCHEMBL10174660 0.75 ERN1 (0.51) CDK4CCND1DYRK1ACDK5KDR
SCHEMBL15045558 0.74 GAA (0.41) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL3603159 0.73 CDK4 (0.48) CDK4CCND1CDK5CDK1CDK2
SCHEMBL3598248 0.73 HPGD (0.62) CDK4CCND1DYRK1ACDK5KDR
SCHEMBL4429156 0.73 KDM4E (0.44) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL7915531 0.73 ALDH1A1 (0.66) MAPK1KDM4EALDH1A1HPGDHTT
SCHEMBL31691908 0.73 DAO (0.53) CDK4CCND1DYRK1AKDRCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207180-B2 Tricyclic indoles and (4,5-dihydro) indoles NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-26 — — US disclosed
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-03-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES CDC7, CDK7, CDK17 CDK4 64/4885CCND1 113/4885DYRK1A 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback